103 total news stories found.
2011-01-27 | BTEC, the largest biomanufacturing training facility in the U.S. continues to see significant growth in its bioprocesses and analytical services it offers to biotech and pharmaceutical companies.
2011-01-19 | WHO announces plan to fight resistance to malaria drug.
2010-12-17 | EU/India reach agreement on dispute allowing generic medication to pass through EU, increasing access to drugs and generic medication.
2010-12-01 | Antiretroviral trial success and access to medicines discussed.
2010-10-22 | Global Health Progress highlights benefits of investment, including improving access to medicines and economic growth.
2010-10-07 | In next 15 years China is anticipated to join U.S., Europe, and Japan as a leader in biopharmaceutical sector.
2010-10-05 | Mystic Management Systems' ensur Document Control Software has been selected as their choice for quality process enhancement by Athersys of Ohio and Cambridge Polymer Group out of Massachusetts.
2010-10-02 | Global Health Progress' fact sheet summarizes country's plan to improve access to drugs, increase pharmaceutical R&D investment and drive economic growth.
2010-09-29 | Global Health Progress highlights how Brazil's investment in research and development promotes innovation and helps drive the economy.
2010-09-24 | Global Health Progress highlights long-term growth prospects as creating positive ripple across region
2010-09-10 | Global Health Progress supports new drug development to combat "untouchable" diseases.
2010-09-04 | Global Health Progress supports MMV's decision to contribute its intellectual property.
2010-08-21 | Recent Forbes commentary questions PDP's role play in fighting neglected diseases.
2010-07-24 | Report highlights collaboration between Indian communities, biopharmaceutical companies and other international partners.
2010-07-09 | International Policy Network highlights the role of free society institutions in social and economic development in recent report.
2010-05-26 | Study emphasizes importance of "IP Intensive" industries for American productivity, global competitiveness.
2010-04-14 | Today, Crossbeta Biosciences announced that it has successfully completed a financing round of up to EUR2 million and appointed Guus Scheefhals as Chief Executive Officer.
2010-04-10 | Global Health Progress applauds world's poorest countries' ability to access pneumococcal disease vaccines
2009-07-20 | Heptax, the Company's lead compound, reduces cholesterol, triglycerides, blood pressure, liver enzymes, and fasting blood glucose levels in animal models of metabolic syndrome and liver disease. It also raised levels of HDL, the "good cholesterol."
2009-07-14 | Norwich Pharmaceuticals, Inc., a perennial industry leader in contract manufacturing and packaging, has announced the formation of a strategic alliance with Emerson Resources, Inc.